Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liming Weng

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Microbiological Methods|October 24, 2009
A self-deleting Cre-lox-ermAM cassette, Cheshire, for marker-less gene deletion in Streptococcus pneumoniaeLiming Weng, Indranil Biswas, Donald A Morrison
Plos One|May 30, 2013
Exit from competence for genetic transformation in Streptococcus pneumoniae is regulated at multiple levelsLiming Weng, Andrew Piotrowski, Donald A Morrison
Pharmacogenomics|February 12, 2013
Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapyLiming Weng, Li Zhang, Yan Peng, et al.
Plos One|April 5, 2014
Integrative "omic" analysis for tamoxifen sensitivity through cell based modelsLiming Weng, Dana Ziliak, Bonnie Lacroix, et al.
Metabolic Syndrome and Related Disorders|February 10, 2015
Association of branched and aromatic amino acids levels with metabolic syndrome and impaired fasting glucose in hypertensive patientsLiming Weng, Eoin Quinlivan, Yan Gong, et al.
Physiological Genomics|November 5, 2015
Genetic loci associated with nonobstructive coronary artery disease in Caucasian womenLiming Weng, Kent D Taylor, Yii-Der Ida Chen, et al.
Metabolomics : Official Journal of the Metabolomic Society|February 21, 2017
Presence of arachidonoyl-carnitine is associated with adverse cardiometabolic responses in hypertensive patients treated with atenololLiming Weng, Yan Gong, Jeffrey Culver, et al.
Circulation. Cardiovascular Genetics|March 15, 2014
Is diabetes mellitus-linked amino acid signature associated with β-blocker-induced impaired fasting glucose?Rhonda M Cooper-Dehoff, Wei Hou, Liming Weng, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Microbiological Methods|October 24, 2009
A self-deleting Cre-lox-ermAM cassette, Cheshire, for marker-less gene deletion in Streptococcus pneumoniaeLiming Weng, Indranil Biswas, Donald A Morrison
Plos One|May 30, 2013
Exit from competence for genetic transformation in Streptococcus pneumoniae is regulated at multiple levelsLiming Weng, Andrew Piotrowski, Donald A Morrison
Pharmacogenomics|February 12, 2013
Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapyLiming Weng, Li Zhang, Yan Peng, et al.
Plos One|April 5, 2014
Integrative "omic" analysis for tamoxifen sensitivity through cell based modelsLiming Weng, Dana Ziliak, Bonnie Lacroix, et al.
Metabolic Syndrome and Related Disorders|February 10, 2015
Association of branched and aromatic amino acids levels with metabolic syndrome and impaired fasting glucose in hypertensive patientsLiming Weng, Eoin Quinlivan, Yan Gong, et al.
Physiological Genomics|November 5, 2015
Genetic loci associated with nonobstructive coronary artery disease in Caucasian womenLiming Weng, Kent D Taylor, Yii-Der Ida Chen, et al.
Metabolomics : Official Journal of the Metabolomic Society|February 21, 2017
Presence of arachidonoyl-carnitine is associated with adverse cardiometabolic responses in hypertensive patients treated with atenololLiming Weng, Yan Gong, Jeffrey Culver, et al.
Circulation. Cardiovascular Genetics|March 15, 2014
Is diabetes mellitus-linked amino acid signature associated with β-blocker-induced impaired fasting glucose?Rhonda M Cooper-Dehoff, Wei Hou, Liming Weng, et al.
Pageof 1